Active	Status	Sponsor type	Region	Phase	Filter
8 Active 5 Inactive 13 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

8 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Feinstein, Jeffrey
NCT03149341: MRI and Computational Simulation Cardiology Study	Enrolling by invitation	N/A	75	US	Magnetic Resonance Imaging	Stanford University	Congenital Heart Disease, Pulmonary Hypertension	01/29	02/29
NCT01571700: Investigation of Dysynchrony in Patients With Pulmonary Hypertension	Enrolling by invitation	N/A	100	US	Catheterization Pacing	Stanford University	Pulmonary Hypertension	12/29	12/29
PPHNet, NCT02249923: Pediatric Pulmonary Hypertension Network () Informatics Registry	Recruiting	N/A	2500	Canada, US		University of Colorado, Denver, National Heart, Lung, and Blood Institute (NHLBI), Johnson & Johnson	Pulmonary Vascular Disease, Pulmonary Arterial Hypertension	12/30	12/31
Adatia, Ian
PPHNet, NCT02249923: Pediatric Pulmonary Hypertension Network () Informatics Registry	Recruiting	N/A	2500	Canada, US		University of Colorado, Denver, National Heart, Lung, and Blood Institute (NHLBI), Johnson & Johnson	Pulmonary Vascular Disease, Pulmonary Arterial Hypertension	12/30	12/31
Krishnan, Usha
MoD, NCT04039464: Mono vs. Dual Therapy for Pediatric Pulmonary Arterial Hypertension	Recruiting	3	100	Canada, US	Mono-Therapy with Sildenafil, Revatio monotherapy, Duo-Therapy with Sildenafil + Bosentan, Dual therapy with Revatio and Tracleer	Johns Hopkins University, National Heart, Lung, and Blood Institute (NHLBI), National Center for Advancing Translational Sciences (NCATS)	Pediatric Pulmonary Hypertension	09/26	09/26
NCT02261883 / 2023-001028-40: Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn	Terminated	2	42	US	IV Remodulin, Treprostinil, Placebo	United Therapeutics, United Therapeutics Corp	Persistent Pulmonary Hypertension of the Newborn	09/22	05/23
PPHNet, NCT02249923: Pediatric Pulmonary Hypertension Network () Informatics Registry	Recruiting	N/A	2500	Canada, US		University of Colorado, Denver, National Heart, Lung, and Blood Institute (NHLBI), Johnson & Johnson	Pulmonary Vascular Disease, Pulmonary Arterial Hypertension	12/30	12/31
Hopper, Rachel
PPHNet, NCT02249923: Pediatric Pulmonary Hypertension Network () Informatics Registry	Recruiting	N/A	2500	Canada, US		University of Colorado, Denver, National Heart, Lung, and Blood Institute (NHLBI), Johnson & Johnson	Pulmonary Vascular Disease, Pulmonary Arterial Hypertension	12/30	12/31